GPT and diabetes mellitus: Patients who progress to severe and critical conditions often have comorbid diabetes, a significant decrease in PaO2, elevated lactate dehydrogenase and creatine kinase levels associated with myocardial enzyme spectrum abnormalities, and liver function changes with elevated AST and ALT levels.